Dexmedetomidine as an Adjuvant to Bupivacaine in Scalp Block Versus Bupivacaine Alone for Postoperative Pain Management in Patients Undergoing Craniotomy
This study compares two ways of blocking pain during scalp surgery for brain procedures. One method uses bupivacaine alone, while the other adds dexmedetomidine to bupivacaine to see which works better for managing pain after surgery.
Key Objective: This trial is testing whether adding dexmedetomidine to a standard pain-blocking injection provides better pain relief after craniotomy surgery.
Who to Consider: Patients scheduled to undergo craniotomy surgery who want to explore potentially improved pain management options after their procedure should consider enrolling.
Trial Parameters
Brief Summary
This study aims to compare dexmedetomidine as an adjuvant to bupivacaine in scalp block versus bupivacaine alone for postoperative pain management in patients undergoing craniotomy.
Eligibility Criteria
Inclusion Criteria: * Age from 18 to 65 years. * Both sexes. * American Society of Anesthesiologists (ASA) physical status I or II. * Undergoing supratentorial elective planned craniotomies. Exclusion Criteria: * Patients refusal. * History of known allergy to the used local anesthetic or dexmedetomidine. * Bleeding disorders. * Evidence of local infection at the site of injection. * Emergency craniotomy. * Psychotic disorder. * Patients who will not be extubated in the operating room after surgery.